|
APC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.254100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.462600E-01 |
| Normal-vs-Stage2 |
2.450600E-01 |
| Normal-vs-Stage3 |
2.036500E-03 |
| Normal-vs-Stage4 |
3.71550000000109E-05 |
| Stage1-vs-Stage2 |
1.851150E-01 |
| Stage1-vs-Stage3 |
1.060310E-03 |
| Stage1-vs-Stage4 |
3.16479999995511E-06 |
| Stage2-vs-Stage3 |
3.689200E-01 |
| Stage2-vs-Stage4 |
7.904100E-02 |
| Stage3-vs-Stage4 |
2.062000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.022200E-02 |
| Normal-vs-AfricanAmerican |
3.704500E-02 |
| Normal-vs-Asian |
3.922600E-01 |
| Caucasian-vs-AfricanAmerican |
2.457000E-01 |
| Caucasian-vs-Asian |
8.867200E-01 |
| AfricanAmerican-vs-Asian |
7.626200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.315300E-03 |
| Normal-vs-Female |
7.665800E-01 |
| Male-vs-Female |
1.120060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.461790E-02 |
| Normal-vs-Age(41-60Yrs) |
2.934000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.811600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.698630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.793190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.340200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.729400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.455000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.255200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.031400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.357900E-02 |
| Normal-vs-Grade 2 |
8.602000E-01 |
| Normal-vs-Grade 3 |
4.779900E-03 |
| Normal-vs-Grade 4 |
1.30289999999977E-06 |
| Grade 1-vs-Grade 2 |
5.389900E-02 |
| Grade 1-vs-Grade 3 |
4.962600E-04 |
| Grade 1-vs-Grade 4 |
2.900600E-03 |
| Grade 2-vs-Grade 3 |
1.483520E-03 |
| Grade 2-vs-Grade 4 |
2.80359999993429E-07 |
| Grade 3-vs-Grade 4 |
6.717300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.790100E-02 |
| Normal-vs-ccB subtype |
1.834230E-04 |
| ccA subtype-vs-ccB subtype |
3.84660003849291E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.124570E-01 |
| Normal-vs-N1 |
2.537300E-03 |
| N0-vs-N1 |
9.278300E-02 |
|
|
